References
- Orr B, Edwards RP. Diagnosis and treatment of ovarian cancer. Hematol Oncol Clin North Am. 2018;32(6):943–964. doi:https://doi.org/10.1016/j.hoc.2018.07.010
- Mallen AR, Townsend MK, Tworoger SS. Risk factors for ovarian carcinoma. Hematol Oncol Clin North Am. 2018;32(6):891–902. doi:https://doi.org/10.1016/j.hoc.2018.07.002
- Bristow RE, Puri I, Chi DS. Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis. Gynecol Oncol. 2009;112(1):265–274. doi:https://doi.org/10.1016/j.ygyno.2008.08.033
- Pignata S, Scambia G, Bologna A, Signoriello S, Vergote IB, Wagner U, Lorusso D, Murgia V, Sorio R, Ferrandina G, et al. Randomized controlled trial testing the efficacy of platinum-free interval prolongation in advanced ovarian cancer: the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study. J Clin Oncol. 2017;35(29):3347–3353. doi:https://doi.org/10.1200/JCO.2017.73.4293
- Pokhriyal R, Hariprasad R, Kumar L, Hariprasad G. Chemotherapy resistance in advanced ovarian cancer patients. Biomark Cancer. 2019;11:1179299X19860815. doi:https://doi.org/10.1177/1179299X19860815
- World Health Organization. Interim Summary of Conclusions and Dietary Recommendations on Total Fat & Fatty Acids. 2010.
- National Institutes of Health, Office of Dietary Supplements. Omega-3 fatty acids, fact sheet for health professionals. 2018.
- Wassall SR, Stillwell W. Docosahexaenoic acid domains: the ultimate non-raft membrane domain. Chem Phys Lipids. 2008;153(1):57–63. doi:https://doi.org/10.1016/j.chemphyslip.2008.02.010
- Ma DWL, Seo J, Switzer KC, Fan Y-Y, McMurray DN, Lupton JR, Chapkin RS. N–3 PUFA and membrane microdomains: a new frontier in bioactive lipid research. J Nutr Biochem. 2004;15(11):700–706. doi:https://doi.org/10.1016/j.jnutbio.2004.08.002
- Blanckaert V, Ulmann L, Mimouni V, Antol J, Brancquart L, Chenais B. Docosahexaenoic acid intake decreases proliferation, increases apoptosis and decreases the invasive potential of the human breast carcinoma cell line MDA-MB-231. Int J Oncol. 2010;36(3):737–742. doi:https://doi.org/10.3892/ijo_00000549
- Corsetto PA, Montorfano G, Zava S, Jovenitti IE, Cremona A, Berra B, Rizzo AM. Effects of n-3 PUFAs on breast cancer cells through their incorporation in plasma membrane. Lipids Health Dis. 2011;10:73. doi:https://doi.org/10.1186/1476-511X-10-73
- Sawyer M, Field CJ. Possible mechanisms for omega-3 (n-3) the anti-tumor action. In: Carviello G, Serini S, editors. Diet and Cancer. 2010. New York (NY): Springer Publishing; 2010. p. 3–40.
- Han L, Zhang Y, Meng M, Cheng D, Wang C. Eicosapentaenoic acid induced SKOV-3 cell apoptosis through ERK1/2-mTOR-NF-κB pathways. Anticancer Drugs. 2016;27(7):635–642. doi:https://doi.org/10.1097/CAD.0000000000000373
- Zajdel A, Kałucka M, Chodurek E, Wilczok A. DHA but not AA enhances cisplatin cytotoxicity in ovarian cancer cells. Nutr Cancer. 2018;70(7):1118–1125. doi:https://doi.org/10.1080/01635581.2018.1497673
- Sharma A, Belna J, Logan J, Espat J, Hurteau JA. The effects of omega-3 fatty acids on growth regulation of epithelial ovarian cancer cell lines. Gynecol Oncol. 2005;99(1):58–64. doi:https://doi.org/10.1016/j.ygyno.2005.05.024
- Tanaka A, Yamamoto A, Murota K, Tsujiuchi T, Iwamori M, Fukushima N. Polyunsaturated fatty acids induce ovarian cancer cell death through ROS-dependent MAP kinase activation. Biochem Biophys Res Commun. 2017;493(1):468–73. doi:https://doi.org/10.1016/j.bbrc.2017.08.168
- Wang Y-C, Wu Y-N, Wang S-L, Lin Q-H, He M-F, Liu Q-l, Wang J-H. Docosahexaenoic acid modulates invasion and metastasis of human ovarian cancer via multiple molecular pathways. Int J Gynecol Cancer. 2016;26(6):994–1003. doi:https://doi.org/10.1097/IGC.0000000000000746
- Hardman WE, Moyer MP, Cameron IL. Dietary fish oil sensitizes A549 lung xenografts to doxorubicin chemotherapy. Cancer Lett. 2000;151(2):145–151. doi:https://doi.org/10.1016/S0304-3835(99)00396-1
- Yang T, Fang S, Zhang H-X, Xu L-X, Zhang Z-Q, Yuan K-T, Xue C-L, Yu H-L, Zhang S, Li Y-F, et al. N-3 PUFAs have antiproliferative and apoptotic effects on human colorectal cancer stem-like cells in vitro. J Nutr Biochem. 2013;24(5):744–753. doi:https://doi.org/10.1016/j.jnutbio.2012.03.023
- Fahrmann JF, Hardman WE. Omega 3 fatty acids increase the chemo-sensitivity of B-CLL-derived cell lines EHEB and MEC-2 and of B-PLL-derived cell line JVM-2 to anti-cancer drugs doxorubicin, vincristine and fludarabine. Lipids Health Dis. 2013;12:36. doi:https://doi.org/10.1186/1476-511X-12-36
- Gao K, Liang Q, Zhao Z-H, Li Y-F, Wang S-F. Synergistic anticancer properties of docosahexaenoic acid and 5-fluorouracil through interference with energy metabolism and cell cycle arrest in human gastric cancer cell line AGS cells. WJG. 2016;22(10):2971–2980. doi:https://doi.org/10.3748/wjg.v22.i10.2971
- Ewaschuk JB, Newell M, Field CJ. Docosahexanoic acid improves chemotherapy efficacy by inducing CD95 translocation to lipid rafts in ER– breast cancer cells. Lipids. 2012;47(11):1019–1030. doi:https://doi.org/10.1007/s11745-012-3717-7
- Newell M, Goruk S, Mazurak V, Postovit L, Field CJ. Role of docosahexaenoic acid in enhancement of docetaxel action in patient-derived breast cancer xenografts. Breast Cancer Res Treat. 2019;177(2):357–367. doi:https://doi.org/10.1007/s10549-019-05331-8
- Yee LD, Lester JL, Cole RM, Richardson JR, Hsu JC, Li Y, Lehman A, Belury MA, Clinton SK. Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition. Am J Clin Nutr. 2010;91(5):1185–1194. doi:https://doi.org/10.3945/ajcn.2009.29036
- Bougnoux P, Hajjaji N, Ferrasson MN, Giraudeau B, Couet C, Le Floch O. Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial. Br J Cancer. 2009; 101(12):1978–1985. doi:https://doi.org/10.1038/sj.bjc.6605441
- Morland SL, Martins KJB, Mazurak VC. N-3 polyunsaturated fatty acid supplementation during cancer chemotherapy. J Nutr Intermed Metab. 2016;5:107–116. doi:https://doi.org/10.1016/j.jnim.2016.05.001
- Yoshida GJ. Applications of patient-derived tumor xenograft models and tumor organoids. J Hematol Oncol. 2020;13(1):4. doi:https://doi.org/10.1186/s13045-019-0829-z
- Karst AM, Drapkin R. Primary culture and immortalization of human fallopian tube secretory epithelial cells. Nat Protoc. 2012;7(9):1755–1764. doi:https://doi.org/10.1038/nprot.2012.097.
- Feoktistova M, Geserick P, Leverkus M. Crystal violet assay for determining viability of cultured cells. Cold Spring Harb Protoc. 2016;2016(4):pdb.prot087379. doi:https://doi.org/10.1101/pdb.prot087379
- Foucquier J, Guedj M. Analysis of drug combinations: current methodological landscape. Pharmacol Res Perspect. 2015;3(3):e00149. doi:https://doi.org/10.1002/prp2.149
- Field CJ, Ryan EA, Thomson AB, Clandinin MT. Dietary fat and the diabetic state alter insulin binding and the fatty acyl composition of the adipocyte plasma membrane. Biochem J. 1988;253(2):417–424. doi:https://doi.org/10.1042/bj2530417
- Folch J, Lees M, Stanley GHS. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226(1):497–509. doi:https://doi.org/10.1016/S0021-9258(18)64849-5
- Cruz-Hernandez C, Goeuriot S, Giuffrida F, Thakkar SK, Destaillats F. Direct quantification of fatty acids in human milk by gas chromatography. J Chromatogr A. 2013;1284:174–179. doi:https://doi.org/10.1016/j.chroma.2013.01.094
- Fasano E, Serini S, Cittadini A, Calviello G. Long-chain n–3 PUFA against breast and prostate cancer: which are the appropriate doses for intervention studies in animals and humans?Crit Rev Food Sci Nutr. 2017;57(11):2245–2262. doi:https://doi.org/10.1080/10408398.2013.850060
- Wan X-H, Fu X, Ababaikeli G. Docosahexaenoic acid induces growth suppression on epithelial ovarian cancer cells more effectively than eicosapentaenoic acid. Nutr Cancer. 2016;68(2):320–327. doi:https://doi.org/10.1080/01635581.2016.1142581
- Ibarguren M, López DJ, Escribá PV. The effect of natural and synthetic fatty acids on membrane structure, microdomain organization, cellular functions and human health. Biochim Biophys Acta. 2014;1838(6):1518–1528. doi:https://doi.org/10.1016/j.bbamem.2013.12.021
- Stillwell W. The role of polyunsaturated lipids in membrane raft function. Scand J Food Nutr. 2006;50(sup2):107–113. doi:https://doi.org/10.1080/17482970601066165
- Song EA, Kim H. Docosahexaenoic acid induces oxidative DNA damage and apoptosis and enhances the chemosensitivity of cancer cells. IJMS. 2016;17(8):1257. doi:https://doi.org/10.3390/ijms17081257
- Newell M, Baker K, Postovit LM, Field CJ. A critical review on the effect of docosahexaenoic acid (DHA) on cancer cell cycle progression. IJMS. 2017;18(8):1784. doi:https://doi.org/10.3390/ijms18081784
- Corsetto PA, Colombo I, Kopecka J, Rizzo AM, Riganti C. ω-3 Long chain polyunsaturated fatty acids as sensitizing agents and multidrug resistance revertants in cancer therapy. IJMS. 2017;18(12):2770. doi:https://doi.org/10.3390/ijms18122770
- D’Eliseo D, Velotti F. Omega-3 fatty acids and cancer cell cytotoxicity: implications for multi-targeted cancer therapy. JCM. 2016;5(2):15. doi:https://doi.org/10.3390/jcm5020015
- Le T, Shahriari P, Hopkins L, Faught W, Fung Kee Fung M. Prognostic significance of tumor necrosis in ovarian patients treated with neoadjuvant chemotherapy and interval surgical debulking. Int J Gynecol Cancer. 2006;16(3):986–990. doi:https://doi.org/10.1136/ijgc-00009577-200605000-00005
- Wang Y, Wang Y, Zheng W. Cytologic changes of ovarian epithelial cancer induced by neoadjuvant chemotherapy. Int J Clin Exp Pathol. 2013;6(10):2121–2128.
- Pizato N, Luzete BC, Kiffer LFMV, Corrêa LH, de Oliveira Santos I, Assumpção JAF, Ito MK, Magalhães KG. Omega-3 docosahexaenoic acid induces pyroptosis cell death in triple-negative breast cancer cells. Sci Rep. 2018;8(1):1952. doi:https://doi.org/10.1038/s41598-018-20422-0
- Newell M, Mackey JR, Bigras G, Alvarez-Camacho M, Goruk S, Ghosh S, Schmidt A, Miede D, Chisotti A, Postovit L, et al. Comparing docosahexaenoic acid (DHA) concomitant with neoadjuvant chemotherapy versus neoadjuvant chemotherapy alone in the treatment of breast cancer (DHA WIN): protocol of a double-blind, phase II, randomised controlled trial. BMJ Open. 2019;9(9):e030502. doi:https://doi.org/10.1136/bmjopen-2019-030502
- Serini S, Piccioni E, Merendino N, Calviello G. Dietary polyunsaturated fatty acids as inducers of apoptosis: implications for cancer. Apoptosis. 2009;14(2):135–52. doi:https://doi.org/10.1007/s10495-008-0298-2